Abtract

With Chinese economic development, the medical & health reform has finally stepped into a crucial period. CPC published "Healthy China 2030" strategic plan in order to build an “innovational, harmonize, green, opened, and shared” environment for next 14 year’s healthy China construction.

Sanofi, as a leader of pharmaceutical industry and advocate of social responsibility, has been involved in Chinese public health development and supporting the medical & health reform for many years. Sanofi is committed to improve the accessibility of medical products and services and meet the high quality medical and health needs of patients.

Adhering to the principles of friendly exchange and mutual development, Sanofi is glad to take the opportunity to express recommendations about “enhancing health investment”, “rewarding innovation”, “improving drug quality and safety” and “Accelerating accessibility to innovative medicines” on behalf of pharmaceutical enterprises to the Chinese government. Sanofi is determined to serve as the most reliable medical and health partner of China and to contribute to the sustainable development of both economy and society and to create a healthier future.